Their recurrence rate, she said, is comparable to reported rates of disease recurrence after standard mastectomy. Furthermore, the procedure has several advantages over standard mastectomy. "Often, a ...

The risk of isolated locoregional recurrence after initial treatment was 5.6% among young women diagnosed with breast cancer. This was lower than a previously reported 10-year rate of 8% among all ...

To evaluate the clinical benefit of extended endocrine therapy after 5 years of adjuvant treatment with LHRHa in premenopausal women with node-positive, HR-positive early breast cancer.

The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer after they received neoadjuvant treatment and surgery predicted ...

SAN ANTONIO -- Postmastectomy chest-wall irradiation (CWI) for intermediate-risk breast cancer had no impact on long-term survival, results of a large British study showed. After a median follow-up of ...

Patients with early-stage, node-positive breast cancer whose nodes are pathologically tumor-free (ypN0) after neoadjuvant chemotherapy may safely skip post-mastectomy nodal irradiation without ...

References: 1.  Thailand Food and Drug Administration. Public Pharmaceutical Regulatory Information: NERLYNX. Available at: ...

The benefit of regional nodal irradiation in the treatment of breast cancer is well established for patients with pathologically positive axillary nodes, but whether it is also beneficial for patients ...

June 10, 2010 — Surgery to remove solid tumors can trigger metastatic spread. A groundbreaking analysis by Patrice Forget, MD, and colleagues from the Université catholique de Louvain, in ...